User: Guest  Login
Title:

Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients.

Document type:
Journal Article; Article
Author(s):
Knopf, Andreas; Lempart, Justine; Bas, Murat; Slotta-Huspenina, Julia; Mansour, Naglaa; Fritsche, Marie Kristin
Abstract:
The occurrence of squamous cell carcinoma of the tongue (SCCT) of young patients increased. There are still controversies about patient prognosis. The underlying molecular mechanisms remain unclear.276 patients (66 <=45, 210 >45 years) with SCCT were included. Clinical parameters and survival data were assessed. Oncogenes and tumor suppressors were analyzed via immunohistochemistry (p53, CXCR4, p16, EGFR) and qPCR (CDK4, CDKN2A, TP53, MDM2, AKT1, PIK3CA, NRAS, HRAS, KRAS, HGF, MET, EGF, ATM, BRCA1, E2F1, FHIT, RUNX3, STK11, BCL2, CTNNB1).The median overall survival was 142 (<=45 years) and 34 months (>45 years) (p < 0.0001; HR [95%CI]: 0.37 [0.30-0.58]). Disease specific survival in patients <=45 years was with 181 months significantly higher than in patients >45 years (p < 0.0001; HR [95%CI]: 0.33 [0.26-0.57]). Immunhistochemistry visualized a comparable expression of analyzed proteins. QPCR demonstrated in patients <=45 years a higher expression of genes that are associated with carcinogenesis (CTNNB1, STK11, CDKN2A, HGF, MET) as well as tumor suppressors that constitute an enhanced radio-sensitivity (ATM, BRCA1E2F1, FHIT).Derogation of the WNT-CTNNB1-STK11 and CDKN2A-HGF-MET pathway can constitute the carcinogenesis, while the higher expression of radio-sensitizers ATM, BRCA1E2F1 and FHIT can explain the better OS/DSS in young patients.
Journal title abbreviation:
Oncotarget
Year:
2015
Journal volume:
6
Journal issue:
5
Pages contribution:
3443-51
Language:
eng
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/25633809
TUM Institution:
Hals-Nasen-Ohrenklinik und Poliklinik; Institut für Allgemeine Pathologie und Pathologische Anatomie
 BibTeX